Literature DB >> 24504744

Increase of high mobility group box chromosomal protein 1 in eosinophilic chronic rhinosinusitis with nasal polyps.

Daishi Chen1, Mingfeng Mao, Luisa M Bellussi, Desiderio Passali, Lei Chen.   

Abstract

BACKGROUND: Chronic rhinosinusitis with nasal polyps (CRSwNP) is characterized by eosinophil-dominant infiltration in Europe and the United States. However, CRSwNP in Asia has shown different immunopathologic features. High-mobility group protein box 1 (HMGB1) is a DNA-binding protein that has been suggested to be involved in various chronic inflammatory diseases. The objective of this study is to investigate whether HMGB1 is augmented in the Chinese eosinophilic CRSwNP and if non-eosinophilic CRSwNP is associated with interleukin 5 (IL-5), IL-8, and tumor necrosis factor α (TNF-α).
METHODS: Nasal polyps specimens were collected from 41 patients with CRSwNP (20 eosinophilic and 21 non-eosinophilic) undergoing functional endoscopic sinus surgery (FESS). Biopsies of uncinate process, and ethmoidal mucosa from 9 non-CRS patients were used as controls by means of immunohistochemistry (IHC) staining, Western blotting, and quantitative reverse-transcription polymerase chain reaction (qRT-PCR).
RESULTS: HMGB1-positive expression was significantly increased in the epithelium and among the large inflammatory cells infiltration in Eos CRSwNP and non-Eos CRSwNP as compared with controls (p < 0.001). The HMGB1 protein and messenger RNA (mRNA) levels of HMGB1, IL-5, IL-8, and TNF-α were significantly higher in eosinophilic CRSwNP than those from controls and non-eosinophilic CRSwNP, but no significant differences in these markers were found between non-eosinophilic CRSwNP and controls. HMGB1 expression levels correlated significantly and positively with IL-5, IL-8, and TNF-α (rs = 0.665, 0.771, and 0.724, respectively; p < 0.001) and slightly with eosinophil infiltration (rs = 0.149; p = 0.012) and the blood eosinophils count (rs = 0.225; p = 0.001) in all samples.
CONCLUSION: Upregulation of HMGB1 could be a significant marker typically in eosinophilic CRSwNP and it may also contribute to the pathogenesis of CRSwNP along with IL-5, IL-8, and TNF-α.
© 2014 ARS-AAOA, LLC.

Entities:  

Keywords:  Chinese patients; HMGB1 protein; chronic rhinosinusitis with nasal polyps; cytokine; eosinophilic inflammation

Mesh:

Substances:

Year:  2014        PMID: 24504744     DOI: 10.1002/alr.21294

Source DB:  PubMed          Journal:  Int Forum Allergy Rhinol        ISSN: 2042-6976            Impact factor:   3.858


  10 in total

1.  Ethyl pyruvate attenuates murine allergic rhinitis partly by decreasing high mobility group box 1 release.

Authors:  Shan Chen; Yanjun Wang; Guoqing Gong; Jianjun Chen; Yongzhi Niu; Weijia Kong
Journal:  Exp Biol Med (Maywood)       Date:  2015-02-13

Review 2.  HMGB1 in health and disease.

Authors:  Rui Kang; Ruochan Chen; Qiuhong Zhang; Wen Hou; Sha Wu; Lizhi Cao; Jin Huang; Yan Yu; Xue-Gong Fan; Zhengwen Yan; Xiaofang Sun; Haichao Wang; Qingde Wang; Allan Tsung; Timothy R Billiar; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Mol Aspects Med       Date:  2014-07-08

3.  Expression of the receptor for advanced glycation end products, a target for high mobility group box 1 protein, and its role in chronic recalcitrant rhinosinusitis with nasal polyps.

Authors:  Karolina Dzaman; Miroslaw J Szczepanski; Marta Molinska-Glura; Antoni Krzeski; Mariola Zagor
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2014-12-12       Impact factor: 4.291

4.  Eosinophils Modulate CD4(+) T Cell Responses via High Mobility Group Box-1 in the Pathogenesis of Asthma.

Authors:  Eun-Jin Shim; Eunyoung Chun; Hyun-Seung Lee; Bo-Ram Bang; Sang-Heon Cho; Kyung-Up Min; Heung-Woo Park
Journal:  Allergy Asthma Immunol Res       Date:  2014-11-25       Impact factor: 5.764

5.  Physiologic concentrations of HMGB1 have no impact on cytokine-mediated eosinophil survival or chemotaxis in response to Eotaxin-2 (CCL24).

Authors:  Kimberly D Dyer; Helene F Rosenberg
Journal:  PLoS One       Date:  2015-03-16       Impact factor: 3.240

6.  High-mobility group box protein 1 expression in inflammatory diseases of the middle ear.

Authors:  Luisa Maria Bellussi; Carla Vindigni; Serena Cocca; Marie Aimee Gloria Munezero Butorano; Walter Livi; Giulia Corallo; Desiderio Passali
Journal:  Int J Immunopathol Pharmacol       Date:  2017-03-15       Impact factor: 3.219

Review 7.  Chinese Society of Allergy and Chinese Society of Otorhinolaryngology-Head and Neck Surgery Guideline for Chronic Rhinosinusitis.

Authors:  Zheng Liu; Jianjun Chen; Lei Cheng; Huabin Li; Shixi Liu; Hongfei Lou; Jianbo Shi; Ying Sun; Dehui Wang; Chengshuo Wang; Xiangdong Wang; Yongxiang Wei; Weiping Wen; Pingchang Yang; Qintai Yang; Gehua Zhang; Yuan Zhang; Changqing Zhao; Dongdong Zhu; Li Zhu; Fenghong Chen; Yi Dong; Qingling Fu; Jingyun Li; Yanqing Li; Chengyao Liu; Feng Liu; Meiping Lu; Yifan Meng; Jichao Sha; Wenyu She; Lili Shi; Kuiji Wang; Jinmei Xue; Luoying Yang; Min Yin; Lichuan Zhang; Ming Zheng; Bing Zhou; Luo Zhang
Journal:  Allergy Asthma Immunol Res       Date:  2020-03       Impact factor: 5.764

Review 8.  HMGB1 in the Pathogenesis of Nasal Inflammatory Diseases and its Inhibition as New Therapeutic Approach: A Review from the Literature.

Authors:  Luisa Maria Bellussi; Serena Cocca; Giulio Cesare Passali; Desideri Passali
Journal:  Int Arch Otorhinolaryngol       Date:  2017-01-04

9.  Nasal Muco-ciliary transport time alteration: efficacy of 18 B Glycyrrhetinic acid.

Authors:  Desiderio Passali; Chiara Cappello; Giulio Cesare Passali; Cemal Cingi; Codrut Sarafoleanu; Luisa Maria Bellussi
Journal:  Multidiscip Respir Med       Date:  2017-11-29

10.  Agonist of PPAR-γ Reduced Epithelial-Mesenchymal Transition in Eosinophilic Chronic Rhinosinusitis with Nasal Polyps via Inhibition of High Mobility Group Box1.

Authors:  Pingli Yang; Shan Chen; Gang Zhong; Weijia Kong; Yanjun Wang
Journal:  Int J Med Sci       Date:  2019-11-09       Impact factor: 3.738

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.